Basal glucose homeostasis with and without fixed concentrations of glucagon and insulin. 1987

R A Jackson, and J B Hamling, and B M Sim, and P M Blix, and J B Jaspan, and S Markanday, and J D Nabarro

The aim of this study was to investigate the extent to which the basal steady state could be maintained with fixed concentrations of glucagon and insulin. To this end, arterial plasma glucose concentrations and peripheral glucose uptake (using the forearm technique) were compared in healthy men (age 19 to 23 years) in the normal postabsorptive state and after suppression of endogenous pancreatic secretion. Two groups (A and B), each consisting of four men, were studied. In group A, the study comprised a control period (I) of 40 minutes followed by a test period (II) of 180 minutes during which normal pancreatic secretion was maintained throughout. In group B, the study comprised a control period (I) of 40 minutes, a stabilization period (II) of 120 minutes, and a test period (III) of 120 minutes. After the control period with normal pancreatic secretion, a new steady state with fixed hormone concentrations was established during the first 90 minutes of period II using simultaneous infusions of somatostatin (250 micrograms/h), insulin (0.15 mU/kg/min) and glucagon, the latter being adjusted to maintain a stable arterial glucose level similar to the preceding control concentration. Thereafter, without further adjustment of the glucagon infusion rate, observations were continued during period III to assess the maintenance of the steady state. In group A, the range of variation in arterial glucose concentrations during periods I and II was 4.0 +/- 0.9 and 6.5 +/- 1.3 mg/dL, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone

Related Publications

R A Jackson, and J B Hamling, and B M Sim, and P M Blix, and J B Jaspan, and S Markanday, and J D Nabarro
August 2006, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
R A Jackson, and J B Hamling, and B M Sim, and P M Blix, and J B Jaspan, and S Markanday, and J D Nabarro
January 1977, Annales de recherches veterinaires. Annals of veterinary research,
R A Jackson, and J B Hamling, and B M Sim, and P M Blix, and J B Jaspan, and S Markanday, and J D Nabarro
April 1986, Metabolism: clinical and experimental,
R A Jackson, and J B Hamling, and B M Sim, and P M Blix, and J B Jaspan, and S Markanday, and J D Nabarro
February 1977, Diabetes,
R A Jackson, and J B Hamling, and B M Sim, and P M Blix, and J B Jaspan, and S Markanday, and J D Nabarro
January 1975, The Journal of clinical investigation,
R A Jackson, and J B Hamling, and B M Sim, and P M Blix, and J B Jaspan, and S Markanday, and J D Nabarro
January 1977, Proceedings of the National Academy of Sciences of the United States of America,
R A Jackson, and J B Hamling, and B M Sim, and P M Blix, and J B Jaspan, and S Markanday, and J D Nabarro
March 1986, The Journal of clinical investigation,
R A Jackson, and J B Hamling, and B M Sim, and P M Blix, and J B Jaspan, and S Markanday, and J D Nabarro
January 1969, JAMA,
R A Jackson, and J B Hamling, and B M Sim, and P M Blix, and J B Jaspan, and S Markanday, and J D Nabarro
May 1981, Research in veterinary science,
R A Jackson, and J B Hamling, and B M Sim, and P M Blix, and J B Jaspan, and S Markanday, and J D Nabarro
January 1993, Nutrition (Burbank, Los Angeles County, Calif.),
Copied contents to your clipboard!